Cargando...

Diabetes and gout: efficacy and safety of febuxostat and allopurinol

Aim Assess influences of demographics and co-morbidities of gout patients with or without diabetes on safety and efficacy of urate-lowering agents. Methods Post-hoc analysis of 312 diabetic and 1957 non-diabetic gout patients [baseline serum urate levels (sUA) ≥8.0 mg/dl] enrolled in a 6-month rando...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Becker, M A, MacDonald, P A, Hunt, B J, Jackson, R L
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2013
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902994/
https://ncbi.nlm.nih.gov/pubmed/23683134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12135
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!